Net Cash Provided by (Used in) Investing Activities in USD of BioAge Labs, Inc. from 2023 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
BioAge Labs, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from 2023 to Q1 2025.
  • BioAge Labs, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2025 was -$78M.
  • BioAge Labs, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was -$366K, a 37.6% decline from 2023.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)

BioAge Labs, Inc. Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$78M -$78M Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q1 2024 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06

BioAge Labs, Inc. Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$366K -$100K -37.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-20
2023 -$266K Jan 1, 2023 Dec 31, 2023 10-K 2025-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.